Literature DB >> 11717357

Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults.

Y Hashimoto1, T Niikura, Y Ito, H Sudo, M Hata, E Arakawa, Y Abe, Y Kita, I Nishimoto.   

Abstract

A novel factor, termed Humanin (HN), antagonizes against neurotoxicity by various types of familial Alzheimer's disease (AD) genes [V642I and K595N/M596L (NL) mutants of amyloid precursor protein (APP), M146L-presenilin (PS) 1, and N141I-PS2] and by Abeta1-43 with clear action specificity ineffective on neurotoxicity by polyglutamine repeat Q79 or superoxide dismutase 1 mutants. Here we report that HN can also inhibit neurotoxicity by other AD-relevant insults: other familial AD genes (A617G-APP, L648P-APP, A246E-PS1, L286V-PS1, C410Y-PS1, and H163R-PS1), APP stimulation by anti-APP antibody, and other Abeta peptides (Abeta1-42 and Abeta25-35). The action specificity was further indicated by the finding that HN could not suppress neurotoxicity by glutamate or prion fragment. Against the AD-relevant insults, essential roles of Cys(8) and Ser(14) were commonly indicated, and the domain from Pro(3) to Pro(19) was responsible for the rescue action of HN, in which seven residues turned out to be essential. We also compared the neuroprotective action of S14G HN (HNG) with that of activity-dependent neurotrophic factor, IGF-I, or basic FGF for the antagonism against various AD-relevant insults (V642I-APP, NL-APP, M146L-PS1, N141I-PS2, and Abeta1-43). Although all of these factors could abolish neurotoxicity by Abeta1-43, only HNG could abolish cytotoxicities by all of them. HN and HN derivative peptides may provide a new insight into the study of AD pathophysiology and allow new avenues for the development of therapeutic interventions for various forms of AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717357      PMCID: PMC6763898     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

2.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein.

Authors:  Y Hashimoto; Y Ito; T Niikura; Z Shao; M Hata; F Oyama; I Nishimoto
Journal:  Biochem Biophys Res Commun       Date:  2001-05-04       Impact factor: 3.575

4.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

5.  Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner.

Authors:  T Niikura; Y Hashimoto; T Okamoto; Y Abe; T Yasukawa; M Kawasumi; T Hiraki; Y Kita; K Terashita; K Kouyama; I Nishimoto
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

6.  Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells.

Authors:  D Platika; M H Boulos; L Baizer; M C Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  V642I APP-inducible neuronal cells: a model system for investigating Alzheimer's disorders.

Authors:  T Niikura; N Murayama; Y Hashimoto; Y Ito; Y Yamagishi; M Matsuoka; Y Takeuchi; S Aiso; I Nishimoto
Journal:  Biochem Biophys Res Commun       Date:  2000-08-02       Impact factor: 3.575

8.  Antibody-regulated neurotoxic function of cell-surface beta-amyloid precursor protein.

Authors:  H Sudo; H Jiang; T Yasukawa; Y Hashimoto; T Niikura; M Kawasumi; S Matsuda; Y Takeuchi; S Aiso; M Matsuoka; Y Murayama; I Nishimoto
Journal:  Mol Cell Neurosci       Date:  2000-12       Impact factor: 4.314

9.  Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue.

Authors:  I Kaneko; N Yamada; Y Sakuraba; M Kamenosono; S Tutumi
Journal:  J Neurochem       Date:  1995-12       Impact factor: 5.372

10.  Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation.

Authors:  B Wolozin; K Iwasaki; P Vito; J K Ganjei; E Lacanà; T Sunderland; B Zhao; J W Kusiak; W Wasco; L D'Adamio
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

View more
  61 in total

1.  Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats.

Authors:  Gao-Shang Chai; Dong-Xiao Duan; Rong-Hong Ma; Jian-Ying Shen; Hong-Lian Li; Zhi-Wei Ma; Yu Luo; Lu Wang; Xin-Hua Qi; Qun Wang; Jian-Zhi Wang; Zelan Wei; Darrell D Mousseau; Li Wang; Gongping Liu
Journal:  Neurosci Bull       Date:  2014-11-12       Impact factor: 5.203

2.  Humanin protects cortical neurons from ischemia and reperfusion injury by the increased activity of superoxide dismutase.

Authors:  Shen-Ting Zhao; Xiao-Tian Huang; Ce Zhang; Ya Ke
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

3.  Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes.

Authors:  Shingo Kariya; Nobuyuki Takahashi; Makito Hirano; Satoshi Ueno
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

4.  Construction of a eukaryotic expression plasmid of Humanin.

Authors:  Ben-yan Luo; Xiang-ming Chen; Min Tang; Feng Chen; Zhi Chen
Journal:  J Zhejiang Univ Sci B       Date:  2005-01       Impact factor: 3.066

5.  The effects of humanin and its analogues on male germ cell apoptosis induced by chemotherapeutic drugs.

Authors:  Yue Jia; Aikoui Ohanyan; Yan-He Lue; Ronald S Swerdloff; Peter Y Liu; Pinchas Cohen; Christina Wang
Journal:  Apoptosis       Date:  2015-04       Impact factor: 4.677

6.  Humanin Derivatives Inhibit Necrotic Cell Death in Neurons.

Authors:  Aviv Cohen; Jenny Lerner-Yardeni; David Meridor; Roni Kasher; Ilana Nathan; Abraham H Parola
Journal:  Mol Med       Date:  2015-06-04       Impact factor: 6.354

7.  Circulating humanin levels are associated with preserved coronary endothelial function.

Authors:  R J Widmer; A J Flammer; J Herrmann; M Rodriguez-Porcel; J Wan; P Cohen; L O Lerman; A Lerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

8.  Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium.

Authors:  Tsutomu Arakawa; Takako Niikura; Hirohisa Tajima; Fumio Arisaka; Yoshiko Kita
Journal:  J Mol Neurosci       Date:  2007-05-31       Impact factor: 3.444

Review 9.  Protective effects of Humanin and calmodulin-like skin protein in Alzheimer's disease and broad range of abnormalities.

Authors:  Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2014-06-27       Impact factor: 5.590

10.  Humanin: a novel central regulator of peripheral insulin action.

Authors:  Radhika H Muzumdar; Derek M Huffman; Gil Atzmon; Christoph Buettner; Laura J Cobb; Sigal Fishman; Temuri Budagov; Lingguang Cui; Francine H Einstein; Aruna Poduval; David Hwang; Nir Barzilai; Pinchas Cohen
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.